Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney Disease
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether a diuretic drug called amiloride is capable
of increasing renal salt excretion and thereby decrease blood pressure in diabetic patients
with kidney disease. Our hypothesis states that amiloride is capable of reducing blood
pressure in these patients and thus decrease the cardiovascular risk associated with diabetic
kidney disease.
Phase:
N/A
Details
Lead Sponsor:
University of Southern Denmark
Collaborators:
Danish Heart Foundation Odense University Hospital Region of Southern Denmark The Ministry of Science, Technology and Innovation, Denmark